562aa1bb-figure-01 (562aa1bb Figure 01)
Gabapentin
Product Images NDC 16590-102
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 16590-102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Stat Rx Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
562aa1bb-figure-02 (562aa1bb Figure 02)
The text is a chart or graph showing the mean pain score during a 4-week dose titration period and a 4-week fixed-dose period. There are two groups: the placebo group and the Gabapentin group, who were given a dose of 3600 mg/day. The chart indicates that the Gabapentin group had significantly lower pain scores compared to the placebo group.*
562aa1bb-figure-03 (562aa1bb Figure 03)
This is a clinical chart showing the mean pain score during a 3-week dose titration period and a 4-week fixed dose period of a placebo group, a group receiving 1800 mg/day of Gabapentin, and a group receiving 2400 mg/day of Gabapentin. The chart shows a decrease in mean pain score in all groups, especially in the Gabapentin groups, with statistical significance (p<0.01).*
562aa1bb-figure-04 (562aa1bb Figure 04)
The text provides a chart with the percentage of responders at the endpoint for Study 1 and Study 2. It also includes the statistical significance levels for each group. However, the content of the chart is not clear due to missing labels or context.*
562aa1bb-figure-05 (562aa1bb Figure 05)
562aa1bb-figure-06 (562aa1bb Figure 06)
562aa1bb-figure-07 (562aa1bb Figure 07)
562aa1bb-figure-08 (562aa1bb Figure 08)
Label Image (Gabapentin 100mg Label)
This is a description of a medication package that contains Gabapentin capsules, with each capsule having 100 mg of the active ingredient. The package has an NDC number of 16590-101-90 and a lot number of SAHPLE. The medication is distributed by a company called R USA Ganesle and is labeled by a company called Hig By belh. The package has a discard after date of 01113.*
Label Image (Gabapentin 300mg Label)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
